pharma · Cancer on the prostatic bed · Prostate cancer at risk of developing metastatic lesions
A.C.O.M. - Advanced
A.C.O.M. - Advanced Center Oncology
A.C.O.M. - Advanced clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
EU HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Programs
- 2
- Drugs
- 4
- Patents
- 1
A.C.O.M. - Advanced projects
0 ClinicalTrials.gov programs sponsored by A.C.O.M. - Advanced.
A.C.O.M. - Advanced has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does A.C.O.M. - Advanced have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.